Human leishmaniasls comprises a &verse group of diseases caused by protozoa of the genus Lelshmama.
In leishmaniasis, macrophages are known to play a central role as modulators of the speafic immune actiwty. In this artMe, Hetdrun Moll presents evidence for the crmcal involvement of another component of the skin immune system, the epMermal Langerhans cell. She proposes that Langerhans cells take up parasttes m the skin and transport them to the draining lymph node for presentation to T cells and imtiatzon of the specific immune response.
Human leishmaniasls comprises a &verse group of diseases caused by protozoa of the genus Lelshmama.
The parasites belong to the famdy Trypanosomatidae; they alternate between the promastlgote form in the sandfly vector and the obligatory mtracellular amasngote form in the mammahan host. The diseases vary in seventy from the naturally heahng cutaneous lexshmaniasis (oriental sore), which is characterized by a localized skin lesion at the site of the sandfly's bite, to the potennally fatal visceral lelshmaniasls (kala-azar), in which the parasites &sseminate from the site of refection and invade lymph nodes, spleen, liver and bone marrow. The chnical manffestanon depends primarily on the species of parasite, but it also revolves the generic bas!s of the host's abdity to develop an effective cell-medmted ~mmune response, thus resembling the situation in leprosy. The spectrum of disease patterns seen m humans can be reproduced by experimental mfecnon of mxce with Letshmania malor, the cause of cutaneous leishmaniasis in the Old World. This mouse model has provided a wealth of informanon on the immune mechamsms underlying host resistance or suscepnbdlty to leishmaniasis, with lmphcanons for a number of mfecuous &s-eases. The outcome of murme refection with L. malor is not influenced by humoral immumty but appears to be determined by CD4 ÷ helper T cells (TH cells) with different patterns of lymphokme actiwty. Thus, protective immumty can be attributed to THl-hke cells producing interferon-gamma (IFN-T), whereas TH2-hke cells releasing interleukm 4 (IL-4) and !L-10 facihtate survxval of the parasitesk On the other hand, the findrags that L. malor-spec~fic THI cells can also exacerbate disease-' and that local mlecnon of IL-4 has a therapeunc effect 3 have emphasized the complexity of the interplay between the parasite and the host immune system.
Early events in Leisbmania infection
Resistance to L. malor refection can be induced m generically susceptible mice by various treatments, for example, sublethal irra&atlon, lmmumzanon with parasite antigen or treatment w~th anti-IL-4 antibodies. In most cases, however, such manipulanons are only effective if performed before refection or during the first week, probably because the dlffere,~_tlal stimulatton of Tu-cell subsets ~s mmated w~thm three days after moculanon of parasttes 4. These fmdmgs emphasize the importance of the early phase of infection. 
Langerhans cells -a component of the dendritic cell system
Langerhans cells are derived from the bone marrow. They have a pronounced dendritic shape and can be identified, at the ultrastructural level, by organelles in their cytoplasm, termed Birbeck granules (reviewed in Ref. WhH~ rhpv l~r~rn~ remarkably similar to the dendritic cells found in lymphoid organs t3. These observations showed that cultured Langerhans cells are m vttro equivalents of Langerhans cells that have ingested and processed antigen in the skin and have then migrated to the draining lymph node while developing into lymphoid dendriuc cells tz~4. Indeed, this translocation of Langerhans cells has been documented in wvo after eDcutaneous apphcation of contact allergen¢ ~a6. It would be an efficient mechanism for transport of anngen from the site of first encounter in the skin to the draining lymph node where a large variety of T cells can be found for inination of the specific immune response.
Evidence for a role of Langerhans cells in leishmaniasis
The function of Langerhans cells m vwo has been analysed using contact hypersensitivity and skin transplantauon as convenient models. However, the involvement of Langerhans cells during infectious diseases is only established for viral infections, such as human immunodeficiency virus and herpes simplex virus. With regard to skin-borne diseases caused by intracellular bacteria or parasites, there are reports on the distribution and turnover of Langerhans cells ~7-19, but their function has not been defined. Attempts to address this issue by performmg manipulations that result in an alteration of Langerhans cell density in the skin (for example, ultraviolet B irradiation, tape stripping or steroid treatmenO have produced conflicting results depending on the type of infectious agent and the mode of treatment*S-2L Furthermore, the contribution of Langerhans cells to the observed effects is difficult to evaluate because those treatments also affect other components of the skin immune system.
Parasite ingestion by Langerbans cells
We have assessed the function of Langerhans cells in experimental cutaneous leishmamasis with L. major. Although Langerhans cells are considered to be minimally phagocytic, they express receptors for the complement component C3bi (CR3), which opsonizes Lezsbmania parasites for macrophages 22"z3. This would favor the idea that they can interact with these organisms. Indeed, Langerhans cells were able to phagocytose intact parasites m vttro and m un]o 24. Ingestion of L. malor could be detected only after incubation of amasugotes with freshly isolated Langerhans cells, but not with those cultured for more than 12 h (suggesting that only intracutaneous Langerhans cells display this activity) and was mediated by the CR3. Thus, it is conceivable that phagocytic actlwty is not a general feature of a given cell type, but a property dependent on the state of differentiation and on expression of the receptors that are reqmred for interacuon with the respective particle. In this context, it is of interest that Rels e Sousa and Austyn zs have recently provided evidence for the abihty of Langerhans cells to phagocytose zymosan, the uptake of which correlated with the actiwty of the mannose receptor. Together, these findings unambiguously show that Langerhans cells are able to take up parucles of considerable size.
Presentatton and transport of L. malor by Langerbans cells
As compared with macrophages, the rate of infection and the parasite load of L. major-contaimng Langerhans cells was consistently low. Th~s supports the notion that phagocytosis of L. malor by Langerhans cells is not tamed at clearance of parasites but at acquisition of antigen for presentauon to T cells. Such a concept is in concordance with our finding that epidermal Langerhans cells are potent stimulators of L. majorspecific T-cell proliferation and lymphokine production m vttro 26. In this respect, their activity was found to be much greater than that of macrophages.
In the course of infection with L. major, a dramatic change in the dlstribuuon of Langerhans cells was observed z4'27. A considerable loss of NLDC-14S" Langerhans cells In the segment of the epidermis overlying the parasite-containing infiltrate was concomitant with the appearance of NLDC-145 + cells m the dermal layer of the lesion, some of which contained L. malor. Langerhans cells of the epidermis were found not to be parasitized. These observations strongly suggest that Langerhans cells migrate from the epidermis to the site of mfecuon in the dermis for uptake of L. major parasites. Furthermore, it was possible to demonstrate directly by m vivo tracking that epidermal lmr,.notogy today viewpoint Langerhans cells infected with L. malor have the abd~ty to migrate from the skin to the draining lymph node ~ . Such a translocauon was not seen with infected macrophages under simdar condlnons. The migratory lymph node dendrmc cells presented the transported antigen to L. major-primed T cells in vltro and, most notably, activated resting T cells capable of mediating a parasite-specific delayed-type hypersensltiwty response tn vivo.
The model
On these grounds, 1 propose a central role for Langerhans cells m the early phase of lelshmamasis (Fig. 1) . Upon inoculation of Lelsbmanta into the skin, Langerhans cells migrate from the epidermis to the dermis and take up parasites. The signals reducing this translocatlon may be medhated by hostderived cytokines, such as IL-11] (Refs 28, 29) or tumor necrosis factor-~t (Ref. 30) and/or by parasite-derwed molecules. Whereas macrophages serve as scavengers and are the predominant site of parasite rephcation, the primary functmn of infected Langerhans cells appears to be the transport of orgamsms to the draining lymph nodes where they encounter a large variety of T cells with different specificities. During migration, the Langerhans cells develop into potent antigenpresenting cells with the abdity to stimulate selected, bur lmmunologlcally naive, T cells for initiation of the immune response. As a result, activated T cells with specificity for Leisbmama anugens would emigrate via the blood into the lesion. At this site, infected macrophages as well as paras:re-containing Langerhans cells that remained in the dermis are hkely to present antigen to infiltrating T cells and regulate their effector acnwty, a process that may be enhanced by cascades of locally produced cytokines.
At this point, the question arises whether Langerhans cells should be considered merely as a functional alternative to macrophages m leishmamasLs. Several considerations argue against this supposition: (1) the migratory property of Langerhans cells is a distinctive feature that equips them to act as an outpost of the immune system; (2) Langerhans cells have the capacity to present antigen to T cells with extraordinary efficiency; and (3) Langerhans cells have the unique ability to induce the primary activatmn of antigenspecific T cells.
Thus, the involvement of Langerbans cells m initial events after infection may be a prerequisite for development of the specific cellular immune response. At later stages of refection, the remarkable ability of Langerhans cells to cluster hgh numbers of memory/effector T cells within the skin 3' may be important for maintenance of an effecnve response. On the other hand, macrophage functions are complementary to those of Langerhans cells in leishmaniasls. Their scavenger actw~ty and abdtty, after appropriate activation, to produce high amounts of reactive oxygen and nitrogen metabolites emphasizes their role as the ultimate effector cells during clearance of refection 32. It has yet to be determined whether Langerhans cells use stmilar mechantsms to control intracellular rcpl,catton of parasites. (7) regulate tbetr effector actway by sez,erat mecbamsms mcludmg cytokme secretmn (8) Implications for the course of disease On the basis of the findings discussed above, there are several ,mportant ,mplicatmns for our understandlng of the pathogenes,s of cutaneous leishmamas,s. First, with reference to the development of TH-ceil subsets producing different arrays of lymphokines. It has been suggested that the type of antigen-presenting cell determines the phenotype of responding T cells 33-3s. The described actwmes of Langerhans cells, however, can be detected in res,stant and m susceptible mice, although we observed differences in the rate of refection (H. Moll, unpubhshed) . In fact, the :niuat predominance of L. malor-bearing dendritic cells in lymph nodes draining, the lesions of both types of mice 27 may explain our previous observation that, at the early It is possible that the relative frequencies of different types of anngen-presenting cells, resulting m different densmes of hgands (MHC class lI-peptide) for the T-cell receptor, may mfluence the phenotype of responding T cells 3". In addition, the development of T-cell subsets m wvo may not be restricted exclusively by the antigen-presenting cell, but may be mfluenced by the availabihty of co-stlmulatory stgnals (for example, cytokmes) from other cell types tn the microenvtronment 3s.39.
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wttb MHC class H molecules on the cell surface ( /a ). A proportton of Langerbans cells transports paras,tes from the infected skin to the draining lymph node (4) for presentatton to anttgen-spectfic restmg T cells m the paracortex (5). As a result, actwated T cells emtgrate t,la the blood into the lesion (6), where infected macropbages and Langerhans cells that remain in the dermts
A second ~mplication relates to the role of parasite antigens. The various types of accessory cells may differ in their processing machinery and may thus favor the presentation of distinct anngens or particular epitopes of a given anugen. For example, freshly isolated Langerhans cells reflecting the intra-epidermal stage were found to display numerous acid:c organelles that are probably involved in antigen processmg 4°. These organelles virtually disappear m cultured Langerhans cells -those that resemble lymph node dendnttc cells and have lost the abd~ty to process native proteins, but retain the ability to present peptides ~'4°. Furthermore, MHC class II molecules are more stable and synthesis of invariant chain is increased m Langerhans cells as compared with macrophages 4t. The slow turnover of MHC class II molecules is of parncular interest because it enables antigen-laden dendritic cells to retain immunogemc peptides during migration ~4. Thus, ~t may be possible to charge Langerhans cells w~th purified parasite anngen ex vivo for immumzatton and inducnon of a protective T-cell response m s~tu. Certainly, a more detaded knowledge of these issues will be important for choosing the route and the mode of admimstration of protectwe antigens and, thus, the development of new vaccination strategies. This may help to understand the varying &sease patterns caused by different species of paras:tes and to approach the well-documented phenomenon of parasite persistence in ~mmune hosts.
